Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention

American Heart Journal

Volumn 165, Issue 5, 2013, Pages 778-784

  Ardati, Amer K ^a   Pitt, Bertram ^b   Smith, Dean E ^b   Aronow, Herbert D ^c   Share, David ^d   Moscucci, Mauro ^e   Chetcuti, Stanley ^b   Grossman, P Michael ^b   Gurm, Hitinder S ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ST JOSEPH MERCY HOSPITAL   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICATION THERAPY MANAGEMENT; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SMOKING;

ADRENERGIC BETA-ANTAGONISTS; AGED; ASPIRIN; COLORING AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84876805628     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.01.015     Document Type: Article

References (29)

1. R.L. Frye, P. August, and M.M. Brooks A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
2. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without pci for stable coronary disease N Engl J Med 356 2007 1503 1516
3. W. Hueb, N.H. Lopes, and B.J. Gersh Five-year follow-up of the medicine, angioplasty, or surgery study (mass ii): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 115 2007 1082 1089
4. W.S. Weintraub, J.A. Spertus, and P. Kolm Effect of pci on quality of life in patients with stable coronary disease N Engl J Med 359 2008 677 687
5. T.M. Maddox, P.M. Ho, and M. Roe Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI registry Circ Cardiovasc Qual Outcomes 3 2010 632 641
6. W.B. Borden, R.F. Redberg, and A.I. Mushlin Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention JAMA 305 2011 1882 1889
7. F.L. Lucas, M.A. DeLorenzo, and A.E. Siewers Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001 Circulation 113 2006 374 379
8. F.L. Lucas, A.E. Siewers, and D.J. Malenka Diagnostic-therapeutic cascade revisited: coronary angiography, coronary artery bypass graft surgery, and percutaneous coronary intervention in the modern era Circulation 118 2008 2797 2802
9. P.S. Chan, M.R. Patel, and L.W. Klein Appropriateness of percutaneous coronary intervention JAMA 306 2011 53 61
10. E. Kline-Rogers, D. Share, and D. Bondie Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience J Interv Cardiol 15 2002 387 392
11. M. Moscucci, D. Share, and E. Kline-Rogers The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions J Interv Cardiol 15 2002 381 386
12. A.V. Margulis, N.K. Choudhry, and C.R. Dormuth Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004 Pharmacoepidemiol Drug Saf 2011
13. H.M. Krumholz, M.J. Radford, and Y. Wang National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project JAMA 280 1998 623 629
14. M.R. Patel, A.Y. Chen, and M.T. Roe A comparison of acute coronary syndrome care at academic and nonacademic hospitals Am J Med 120 2007 40 46
15. S.W. Glickman, F.S. Ou, and E.R. DeLong Pay for performance, quality of care, and outcomes in acute myocardial infarction JAMA 297 2007 2373 2380
16. R.M. Werner, and E.T. Bradlow Public reporting on hospital process improvements is linked to better patient outcomes Health Aff 29 2010 1319 1324
17. B. Pitt, D. Waters, and W.V. Brown Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin Versus Revascularization Treatment Investigators N Engl J Med 341 1999 70 76
18. Coronary angioplasty versus medical therapy for angina: the Second Randomised Intervention Treatment of Angina (rita-2) trial. Rita-2 trial participants Lancet 350 1997 461 468
19. W. Hueb, P.R. Soares, and B.J. Gersh The medicine, angioplasty, or surgery study (mass-ii): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results J Am Coll Cardiol 43 2004 1743 1751
20. K. Nishigaki, T. Yamazaki, and A. Kitabatake Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study JACC Cardiovasc Interv 1 2008 469 479
21. M.B. Rothberg, S.K. Sivalingam, and J. Ashraf Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease Ann Intern Med 153 2010 307 313
22. T.J. Wilt, H.E. Bloomfield, and R. MacDonald Effectiveness of statin therapy in adults with coronary heart disease Arch Intern Med 164 2004 1427 1436
23. C. Baigent, A. Keech, and P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
24. B. Mihaylova, A. Briggs, and J. Armitage Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people BMJ 333 2006 1145
25. B.C. Fellstrom, A.G. Jardine, and R.E. Schmieder Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 2009 1395 1407
26. N.A. Mason, G.R. Bailie, and S. Satayathum HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients Am J Kidney Dis 45 2005 119 126
27. G.F. Strippoli, S.D. Navaneethan, and D.W. Johnson Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials BMJ 336 2008 645 651
28. S.D. Navaneethan, S.U. Nigwekar, and V. Perkovic HMG COA reductase inhibitors (statins) for dialysis patients Cochrane Database Syst Rev 2009 CD004289
29. D.A. Share, D.A. Campbell, and N. Birkmeyer How a regional collaborative of hospitals and physicians in Michigan cut costs and improved the quality of care Health Aff 30 2011 636 645